Search Results - "McDonald, Andrew Bruce" :: K.UTB vyhledávací portál

Loading…

$Efficacy and safety of pembrolizumab every six weeks in relapsed/refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma: The phase 2 KEYNOTE-B68 trial$

Efficacy and safety of pembrolizumab every six weeks in relapsed/refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma: The phase 2 KEYNOTE-B68 trial

by McDonald, Andrew Bruce, Verburgh, Estelle, Gotti, Manuel, Pinto, Antonio, Zaucha, Jan, Ivanov, Vladimir, Melnichenko, Vladimir, Mocikova, Heidi, Ozcan, Muhit, Patti, Caterina, Farias, Joao, Goncalves, Iara, Mayer, Jiří, Saydam, Guray, Tomassetti, Sarah, Pathiraja, Kumudu, Ryland, Katherine, Chakraborty, Samhita, Jurczak, Wojciech
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Loading…

$Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma$

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

by McDonald, Andrew Bruce, Verburgh, Estelle, Gotti, Manuel, Pinto, Antonio, Zaucha, Jan Maciej, Ivanov, Vladimir, Melnichenko, Vladimir, Mocikova, Heidi, Ozcan, Muhit, Patti, Caterina, Farias, João, Goncalves, Iara Zapparoli, Kuchkova, Olha, Mayer, Jiří, Saydam, Güray, Tomassetti, Sarah, Pathiraja, Kumudu, Ryland, Katherine Elizabeth, Marinello, Patricia, Jurczak, Wojciech
Published in Blood (02.11.2023)

Get full text

Journal Article